Gregory Burkman1, Gerald V Naccarelli2. 1. Heart and Vascular Institute, Penn State University College of Medicine, 500 University Drive, PO Box 850, Hershey, PA, 17033, USA. gburkman@pennstatehealth.psu.edu. 2. Heart and Vascular Institute, Penn State University College of Medicine, 500 University Drive, PO Box 850, Hershey, PA, 17033, USA.
Abstract
PURPOSE OF REVIEW: Atrial fibrillation and heart failure frequently co-exist with an increasing prevalence of atrial fibrillation as ejection fraction decreases. Atrial fibrillation is associated with increased mortality in patients with heart failure. This article will review rhythm and rate control options, ultimately supporting rhythm control via endocardial ablation. RECENT FINDINGS: Randomized trials of a rhythm control strategy in patients with reduced ejection fraction heart failure have shown significant improvements in ejection fraction, oxygen consumption and also a significant reduction in mortality. The treatment of atrial fibrillation in patients with reduced ejection fraction heart failure should include an early rhythm control strategy via endocardial ablation.
PURPOSE OF REVIEW: Atrial fibrillation and heart failure frequently co-exist with an increasing prevalence of atrial fibrillation as ejection fraction decreases. Atrial fibrillation is associated with increased mortality in patients with heart failure. This article will review rhythm and rate control options, ultimately supporting rhythm control via endocardial ablation. RECENT FINDINGS: Randomized trials of a rhythm control strategy in patients with reduced ejection fraction heart failure have shown significant improvements in ejection fraction, oxygen consumption and also a significant reduction in mortality. The treatment of atrial fibrillation in patients with reduced ejection fraction heart failure should include an early rhythm control strategy via endocardial ablation.
Entities:
Keywords:
Atrial fibrillation; Heart failure; Rhythm control
Authors: George Cholack; Joshua Garfein; Rachel Krallman; Daniel Montgomery; Eva Kline-Rogers; Melvyn Rubenfire; Sherry Bumpus; Thomas Cascino Md; Geoffrey D Barnes Journal: Am J Med Date: 2021-07-07 Impact factor: 5.928